Multicenter prospective study on oral management for preventing medication-related osteonecrosis of the jaw in patients receiving high-dose antiresorptive agent
Not Applicable
- Conditions
- Patients with cancer receiving high-dose antiresorptive agent
- Registration Number
- JPRN-UMIN000039449
- Lead Sponsor
- agasaki University Graduate School of Biomedical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
edentrous patient
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method onset of Medication-related osteonecrosis of the jaw (MRONJ)
- Secondary Outcome Measures
Name Time Method